Vestaron

Vestaron

Private
Durham, North CarolinaHealthcare & Life Scienceshttps://www.vestaron.com

Last Round

VC Round

Mar 27, 2025

Total Funding Raised

$196.95M

Company Overview

Vestaron is an agricultural biotechnology company that develops peptide-based biopesticides to enhance the safety, efficacy, and sustainability of crop protection.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Sustainable Materials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

peptide-based bioinsecticidesbioinsecticidescrop protectionbiopesticidesbiologicalsagtechspider venom insecticideinsect resistance managementnovel mode of actionpollinator safe insecticideIRAC Group 32agricultural biotechnologyactive ingredientBacillus thuringiensisBtk

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Vestaron Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Vestaron Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
VC RoundMar 27, 2025
Series C ExtensionAug 25, 2022
Series CMay 12, 2022
Series B ExtensionFeb 16, 2021
Series BJun 10, 2019
Series D
Aug 8, 2016

Vestaron Investors

Notable investors and investment history

InvestorRounds
Cultivian Sandbox VenturesSeries D, Series C
FortistarSeries C Extension, Series C
Grosvenor Food & AgTechSeries C Extension
Open Prairie VenturesSeries B, Series A, Series C, Series D
Cavallo VenturesSeries B Extension, Series C
Argonautic VenturesSeries C
Anterra CapitalSeries B, Series C, Series B Extension, Series D

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 19, 2025

    George Duko joins as a Business Development Consultant.

Vestaron Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Vestaron Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Vestaron's valuation, stock price, and market status.

Firmographic Details

HeadquartersDurham, North Carolina
Employee Range43
Year Founded2001
Last FundingMar 27, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.